Texas A&M And University of Minnesota Receive Federal Grant to Develop New Mpox Antivirals

The National Institutes of Health (NIH) has awarded a $3.8 million grant to Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) and the University of Minnesota scientists to develop, optimize and test three promising antiviral drugs for treating mpox — formerly known as monkeypox.

Mpox is an infectious disease caused by the monkeypox virus, a species of the genus Orthopoxvirus. It can cause a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain and low energy. Most people fully recover, but others get very sick.